LBP AM’s ResMed RMD Stock Holding History

LBP AM’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$304K	Sell	1,558 -23,148	-94%	-$4.8M	﹤0.01%	411
2026 Q1	$5.55M	Buy	24,706 +1,581	+7%	+$394K	0.08%	196
2025 Q4	$5.57M	Buy	23,125 +18,142	+364%	+$4.64M	0.06%	220
2025 Q3	$1.36M	Sell	4,983 -246	-5%	-$67.2K	0.02%	316
2025 Q2	$1.35M	Sell	5,229 -589	-10%	-$141K	0.02%	301
2025 Q1	$1.3M	Hold	5,818	–	–	0.02%	298
2024 Q4	$1.33M	Buy	5,818 +3,357	+136%	+$808K	0.02%	306
2024 Q3	$601K	Sell	2,461 -2,013	-45%	-$450K	0.01%	325
2024 Q2	$856K	Buy	+4,474	New	+$908K	0.04%	290

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

LBP AM's RMD Position: Q2 2026 in Review

LBP AM reduced its ResMed (RMD) stake by 94% in Q2 2026, selling an estimated $4.8M and leaving 1,558 shares worth $304K. The position accounts for ﹤0.01% of the portfolio, ranked #411.

LBP AM first reported a position in RMD in Q2 2024 and has held it in 9 quarters since. The position peaked at $5.57M in Q4 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

LBP AM held 1,558 shares of ResMed worth $304K as of Q2 2026.
LBP AM sold 23,148 ResMed shares in Q2 2026, an estimated $4.8M.
ResMed made up ﹤0.01% of LBP AM's portfolio in Q2 2026, its #411 holding.
LBP AM first reported a position in ResMed in Q2 2024 and has held it in 9 quarters since.
LBP AM's ResMed position peaked at $5.57M in Q4 2025.
882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on LBP AM's 13F filing for Q2 2026, filed 24 Jul 2026.